RPG Life Sciences rises on deal to acquire API business of Raghava Life Sciences
RPG Life Sciences added 1.29% to Rs 2606 after the company said that its subsidiary RPG Active Pharma would acquire the API and intermediates business of Raghava Life Sciences for Rs 135 crore.
